Inventor · disambiguated record
Frederick Arthur Brookfield
Also filed as: BROOKFIELD FREDERICK · BROOKFIELD FREDERICK A · BROOKFIELD FREDERICK ARTHUR
65 granted patents·17 pending applications·625 citations·filing 2004–2025
99Inventor score
Files withCARDIOXYL PHARMACEUTICALS INC32STORM THERAPEUTICS LTD7HOFFMANN LA ROCHE6RESPIVERT LTD6TOSCANO JOHN P5
Top patents by PatentIndex Score
82 records- 0197US9156804B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2015·Granted Oct 13, 2015·18 cites·26 claims
- 0297USRE45314EN-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2013·Granted Dec 30, 2014·30 cites·46 claims
- 0397US8030356B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2007·Granted Oct 4, 2011·43 cites·23 claims
- 0496US11306056B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2020·Granted Apr 19, 2022·2 cites·15 claims
- 0596US10548872B2Pharmaceutical compositions comprising nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2019·Granted Feb 4, 2020·6 cites·19 claims
- 0696US9586896B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2015·Granted Mar 7, 2017·14 cites·23 claims
- 0796US9487498B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2015·Granted Nov 8, 2016·14 cites·20 claims
- 0896US9221780B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2014·Granted Dec 29, 2015·22 cites·1 claims
- 0996US9018411B2Bis-acylated hydroxylamine derivativesTOSCANO JOHN P·Filed 2010·Granted Apr 28, 2015·15 cites·18 claims
- 1096US8987326B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2014·Granted Mar 24, 2015·21 cites·34 claims
- 1196US8674132B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsTOSCANO JOHN P·Filed 2012·Granted Mar 18, 2014·37 cites·22 claims
- 1296US8227639B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsTOSCANO JOHN P·Filed 2008·Granted Jul 24, 2012·46 cites·21 claims
- 1395US10829445B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2019·Granted Nov 10, 2020·5 cites·8 claims
- 1495US9968584B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2017·Granted May 15, 2018·10 cites·17 claims
- 1595US9458127B2Bis-acylated hydroxylamine derivativesCARDIOXYL PHARMACEUTICALS INC·Filed 2015·Granted Oct 4, 2016·10 cites·31 claims
- 1695US9115064B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsUNIV JOHNS HOPKINS·Filed 2014·Granted Aug 25, 2015·23 cites·19 claims
- 1794US11273143B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2020·Granted Mar 15, 2022·2 cites·11 claims
- 1894US9969684B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2017·Granted May 15, 2018·8 cites·18 claims
- 1994US9725410B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2017·10 cites·20 claims
- 2093US11786501B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2022·Granted Oct 17, 2023·1 cites·11 claims
- 2193US10792273B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2019·Granted Oct 6, 2020·6 cites·19 claims
- 2293US10517847B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2019·Granted Dec 31, 2019·6 cites·19 claims
- 2393US10213408B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2018·Granted Feb 26, 2019·6 cites·19 claims
- 2493US10179765B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2018·Granted Jan 15, 2019·6 cites·2 claims
- 2593US8318705B2Nitroso compounds as nitroxyl donors and methods of use thereofFROST LISA M·Filed 2009·Granted Nov 27, 2012·30 cites·15 claims
- 2692US11725010B2Polyheterocyclic compounds as METTL3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2022·Granted Aug 15, 2023·3 cites·3 claims
- 2792US8791134B2Nitroso compounds as nitroxyl donors and methods of use thereofCARDIOXYL PHARMACEUTICALS INC·Filed 2012·Granted Jul 29, 2014·14 cites·17 claims
- 2892US8106069B2Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising themSALOM BARBARA·Filed 2010·Granted Jan 31, 2012·32 cites·4 claims
- 2991US11304924B2Pharmaceutical compositions comprising nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2020·Granted Apr 19, 2022·2 cites·22 claims
- 3091US10487049B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2019·Granted Nov 26, 2019·5 cites·8 claims
- 3191US8198298B2Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitorsSALOM BARBARA·Filed 2011·Granted Jun 12, 2012·31 cites·14 claims
- 3291US7582672B2Compounds for the treatment of CRTH2-mediated diseases and conditionsOXAGEN LTD·Filed 2004·Granted Sep 1, 2009·32 cites·8 claims
- 3390US12186301B2Nitroxyl donors with improved therapeutic indexCARDIOXYL PHARMACEUTICALS INC·Filed 2023·Granted Jan 7, 2025·0 cites·20 claims
- 3489US10245249B2Pharmaceutical compositions comprising nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2014·Granted Apr 2, 2019·6 cites·49 claims
- 3588US9617208B2N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donorsUNIV JOHNS HOPKINS·Filed 2015·Granted Apr 11, 2017·5 cites·31 claims
- 3687US9725402B2Nitroso compounds as nitroxyl donors and methods of use thereofCARDIOXYL PHARMACEUTICALS INC·Filed 2015·Granted Aug 8, 2017·4 cites·11 claims
- 3786US8883785B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofDOMINGUEZ CELIA·Filed 2011·Granted Nov 11, 2014·15 cites·13 claims
- 3886US8198314B2Treatment of CRTH2-mediated diseases and conditionsMIDDLEMISS DAVID·Filed 2008·Granted Jun 12, 2012·7 cites·17 claims
- 3985US9682938B2Pyrazolone derivatives as nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2015·Granted Jun 20, 2017·6 cites·48 claims
- 4085US8741909B2PI3 kinase inhibitorsKING-UNDERWOOD JOHN·Filed 2010·Granted Jun 3, 2014·7 cites·25 claims
- 4185US8314257B2Treatment of CRTH2-mediated diseases and conditionsMIDDLEMISS DAVID·Filed 2008·Granted Nov 20, 2012·6 cites·27 claims
- 4285US8163936B2Treatment of CRTH2-mediated diseases and conditionsMIDDLEMISS DAVID·Filed 2008·Granted Apr 24, 2012·6 cites·11 claims
- 4385US8163931B2Treatment of CRTH2-mediated diseases and conditionsMIDDLEMISS DAVID·Filed 2008·Granted Apr 24, 2012·6 cites·19 claims
- 4484US7208526B2StyrylsulfonamidesHOFFMANN LA ROCHE·Filed 2006·Granted Apr 24, 2007·9 cites·55 claims
- 4583US9932303B2N-hydroxymethanesulfonamide nitroxyl donorsCARDIOXYL PHARMACEUTICALS INC·Filed 2015·Granted Apr 3, 2018·4 cites·77 claims
- 4683US9732029B2Nitroso compounds as nitroxyl donors and methods of use thereofCARDIOXYL PHARMACEUTICALS INC·Filed 2014·Granted Aug 15, 2017·4 cites·26 claims
- 4782US7226923B2Phthalazinone derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Jun 5, 2007·8 cites·49 claims
- 4878US12358915B2METTL3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2020·Granted Jul 15, 2025·1 cites·18 claims
- 4978US9321773B2CompoundsRESPIVERT LTD·Filed 2014·Granted Apr 26, 2016·2 cites·1 claims
- 5078US8268840B2Pyrimidinyl pyridone inhibitors of kinasesBROOKFIELD FREDERICK·Filed 2009·Granted Sep 18, 2012·8 cites·8 claims
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Frederick Arthur Brookfield files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →